INFLUENCE OF DIGITAL EXAMINATION, CYSTOSCOPY, TRANSRECTAL ULTRASONOGRAPHY AND NEEDLE-BIOPSY ON THE CONCENTRATION OF PROSTATE-SPECIFIC ANTIGEN

被引：23

作者：

DELIVELIOTIS, C

ALIVIZATOS, G

STAVROPOULOS, NJ

MAKRYCHORITIS, K

KOUTSOKALIS, G

KIRIAKAKIS, Z

KOSTAKOPOULOS, A

DIMOPOULOS, C

机构：

[1] Department of Urology, University of Athens, Sismanoglion General Hospital, Athens

来源：

UROLOGIA INTERNATIONALIS | 1994年 / 53卷 / 04期

关键词：

PROSTATE-SPECIFIC ANTIGEN; DIGITAL RECTAL EXAMINATION; CYSTOSCOPY; TRANSRECTAL ULTRASONOGRAPHY; NEEDLE BIOPSY;

D O I：

10.1159/000282670

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

The influence of various prostatic manipulations, including digital rectal examination, cystoscopy, transrectal ultrasonography and transrectal needle biopsy, on the serum prostatic-specific antigen (PSA) levels in 170 men, were examined. We found that digital rectal examination, cystoscopy and transrectal ultrasonography had no significant effect on PSA levels, except for transrectal needle biopsy, which caused an immediate increase of serum PSA in 96.2% of the patients lasting more than 2 weeks in 42.3% of the cases. In conclusion, serum PSA determination after digital rectal examination, after cystoscopy and after transrectal ultrasonography is accurate and reliable. On the other hand, we must wait about 6 weeks after needle biopsy before measuring PSA in the serum of patients with prostatic diseases.

引用

页码：186 / 190

页数：5

共 14 条

[1]

Wang M.C., Valenzuela L.A., Murphy G.P., Chu T., Purification of a human prostate-specific antigen, Invest Urol, 17, pp. 159-163, (1979)

[2]

Oesterling J.E., Prostate-specific antigen: Improving its ability to diagnose early prostate cancer, JAMA, 267, pp. 2236-2238, (1992)

[3]

Stamey T.A., Yang N., Hay A.R., McNeal J.E., Freila F.S., Redwinc E., Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate, N Engl J, 317, pp. 909-916, (1987)

[4]

Oesterling J.E., Chan D.W., Epstein J.I., Kimball A.W., Bruzek D.J., Rock R.C., Brendler C.B., Walch P.C., Prostate-specific antigen in the pre-operative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy, J Urol, 139, pp. 766-772, (1988)

[5]

Hudson M.A., Bahuson R.R., Catalona W.J., Clinical use of prostate-specific antigen in patients with prostate cancer, J Urol, 142, pp. 1011-1017, (1989)

[6]

Stamey T.A., Kabalin J.N., McNeal J.E., Johnstone I.M., Freila F., Redwine F.A., Yang N., Prostate-specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy-treated patients, J Urol, 141, pp. 1076-1083, (1989)

[7]

Partin A.W., Carter H.B., Chan D.W., Epstein J.I., Oesterling J.E., Rock R.C., Weber J.P., Walsh P.C., Prostate-specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume and benign hyperplasia, J Urol, 143, pp. 747-752, (1990)

[8]

Lange P.H., Ercole C.J., Lightner D.J., Fraley E.E., Vessella R., The value of serum prostate-specific antigen determination before and after radical prostatectomy, J Urol, 141, pp. 873-879, (1989)

[9]

Oesterling J.E., Prostate-specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate, J Urol, 145, pp. 907-923, (1991)

[10]

Brawer M.K., Schifman R.B., Ahmann F.R., Ahmann M.E., Coulis K.M., The effect of digital rectal examination on serum levels of prostatic-14 specific antigen, Arch Pathol Lab Med, 112, pp. 1110-1112, (1988)

← 1 2 →